186 results
Page 6 of 10
6-K
EX-99.5
0m378c
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
0t30e4zyl3vpw1bi9ds
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
dncvvft50z
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
rjk0w bjsb
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
l75b6tw
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
rbqdujh 8r13m8ns4n
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
au5492vdl lvk6
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
chjtki4dxw9tnvb49j
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
qfo kk6ykrdi
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
c0qvs7wksrf5
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
no19igb gw8apsuqz
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
9gujsse rv5
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
ntccarwgji99yryb
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
09ac1b5f4 y3pcp
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
59n2r3yp3q8 lkxze
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
jeg1s
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
xqs7ek0 i7t7vcw0
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.1
zcp8r4c9a
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
w1rpt6vb z66mhqkk
26 Nov 18
Current report (foreign)
4:20pm